Option Care Health, Inc. has entered into a definitive agreement to be acquired by an investor group led by Clayton, Dubilier & Rice (CD&R) and McKesson Corporation. The agreement, signed on October 5, 2026, outlines a transaction valued at approximately $5.8 billion, representing an enterprise value of $32.05 per share.
Under the terms of the Merger Agreement, Option Care Health will be merged with and into a wholly owned subsidiary of the buyer. The company will continue as the surviving corporation and will become a wholly owned subsidiary of the buyer. Upon the effective time of the merger, each share of Option Care Health common stock will be cancelled and converted into the right to receive $32.05 in cash per share.
The transaction is structured so that CD&R will hold a majority ownership interest of approximately 51%, while McKesson will acquire a minority interest of approximately 49% for an investment of approximately $1.4 billion. Option Care Health will remain a separate company led by its current management team.
The board of directors of Option Care Health unanimously approved the agreement and recommended that stockholders vote in favor of the transaction. The deal is expected to close in the first half of calendar year 2027, subject to customary closing conditions, including approval by Option Care Health’s stockholders and the receipt of required regulatory approvals.
Following the completion of the transaction, Option Care Health’s common stock will no longer be publicly listed on the Nasdaq Stock Exchange, and the company will become a privately held entity.
